HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Okada Selected Research

Complementary DNA (cDNA)

4/2003An investigation of adverse effects caused by the injection of high-dose TNFalpha-expressing adenovirus vector into established murine melanoma.
11/2001Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Okada Research Topics

Disease

14Neoplasms (Cancer)
06/2017 - 07/2000
7Neoplasm Metastasis (Metastasis)
01/2015 - 10/2001
6Inflammation (Inflammations)
10/2008 - 09/2001
5Biliary Atresia
11/2018 - 12/2010
5Infections
12/2014 - 01/2000
5Carcinoma (Carcinomatosis)
05/2010 - 02/2001
3Hypertension (High Blood Pressure)
12/2018 - 01/2001
3Liver Diseases (Liver Disease)
11/2018 - 03/2012
3Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 10/2001
3Melanoma (Melanoma, Malignant)
10/2008 - 04/2003
3Proteinuria
08/2006 - 02/2000
2Splenomegaly
11/2018 - 05/2016
2End Stage Liver Disease
06/2018 - 12/2010
2Pathologic Constriction (Stenosis)
05/2016 - 04/2014
2Keratoconjunctivitis
06/2012 - 12/2006
2Lymphatic Metastasis
03/2011 - 11/2002
2Colonic Neoplasms (Colon Cancer)
12/2010 - 06/2010
2Dry Eye Syndromes (Dry Eye Syndrome)
06/2010 - 02/2008
2Squamous Cell Carcinoma of Head and Neck
05/2010 - 11/2005
2Diabetic Nephropathies (Diabetic Nephropathy)
08/2006 - 01/2001
2Ischemia
11/2001 - 01/2000
2IGA Glomerulonephritis (IGA Nephropathy)
07/2001 - 02/2000
2Septic Shock (Toxic Shock Syndrome)
04/2001 - 07/2000
2Chronic Kidney Failure (Chronic Renal Failure)
02/2000 - 02/2000
1Delirium
12/2018
1Hypertensive Crisis
12/2018
1Hypothermia
01/2017
1Esophageal Neoplasms (Esophageal Cancer)
01/2017
1Liver Failure
05/2016
1Hepatomegaly
05/2016
1Stomach Neoplasms (Stomach Cancer)
02/2015
1Virus Diseases (Viral Diseases)
12/2014
1Cytomegalovirus Infections (Inclusion Disease)
12/2014
1Refractory Anemia
04/2014
1Iron Overload
04/2014
1Peritoneal Neoplasms
12/2013
1Cardiac Tamponade
01/2013
1Osteomyelitis
10/2012
1Ornithine Carbamoyltransferase Deficiency Disease
09/2012
1Eosinophilia
06/2012
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012
1Mouth Neoplasms (Oral Cancer)
03/2011

Drug/Important Bio-Agent (IBA)

6Complement System Proteins (Complement)IBA
01/2013 - 01/2000
5AntigensIBA
01/2013 - 04/2000
3Messenger RNA (mRNA)IBA
10/2008 - 12/2006
3Indicators and Reagents (Reagents)IBA
09/2003 - 02/2000
2EndotoxinsIBA
06/2018 - 04/2001
2Amino AcidsFDA Link
01/2017 - 01/2000
2AcidsIBA
05/2016 - 01/2001
2Dihydrotachysterol (AT 10)IBA
05/2016 - 04/2003
2PerforinIBA
03/2007 - 04/2006
2Nitric Oxide Synthase (NO Synthase)IBA
08/2006 - 01/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2006 - 01/2001
2VaccinesIBA
01/2005 - 10/2003
2Complementary DNA (cDNA)IBA
04/2003 - 11/2001
2Immunoglobulin A (IgA)IBA
07/2001 - 02/2000
2SodiumIBA
07/2001 - 01/2001
2CreatinineIBA
01/2001 - 02/2000
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2018
1Nicardipine (Dagan)FDA LinkGeneric
12/2018
1Antihypertensive Agents (Antihypertensives)IBA
12/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2018
1Alanine Transaminase (SGPT)IBA
06/2018
1LipidsIBA
06/2017
1Calcineurin InhibitorsIBA
05/2016
1Lactoylglutathione LyaseIBA
02/2015
1EnzymesIBA
02/2015
1S-(4-bromobenzyl)glutathioneIBA
02/2015
1Small Interfering RNA (siRNA)IBA
02/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Muromonab-CD3 (Muromonab CD3)FDA Link
12/2014
1Ferritins (Ferritin)IBA
04/2014
1IronIBA
04/2014
1Transferrin (beta 2 Transferrin)IBA
04/2014
11- palmitoyl- 2- omega- (2- diazo- 3,3,3- trifluoropropionyloxy)lauroyl- sn- glycero- 3- phosphocholineIBA
12/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2013
1Endothelins (Endothelin)IBA
01/2013
1Enterotoxins (Enterotoxin)IBA
06/2012
1ferric oxide (iron oxide)IBA
01/2012
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
01/2012
1ErbB Receptors (EGF Receptor)IBA
03/2011

Therapy/Procedure

11Liver Transplantation
11/2018 - 12/2010
5Therapeutics
10/2012 - 02/2000
3Laparotomy
12/2010 - 10/2001
2Drug Therapy (Chemotherapy)
12/2013 - 02/2013
2Radiotherapy
11/2005 - 04/2000
2Immunotherapy
01/2005 - 10/2003
2Cardiopulmonary Resuscitation (CPR)
04/2001 - 07/2000
1Artificial Respiration (Mechanical Ventilation)
12/2018
1Hepatic Portoenterostomy
11/2018
1Esophagectomy
01/2017
1Stents
05/2016
1Aftercare (After-Treatment)
05/2016
1Transplantation
12/2014
1Blood Transfusion (Blood Transfusions)
04/2014
1Choledochostomy
04/2014
1Chelation Therapy (Therapy, Chelation)
04/2014
1Perioperative Period
04/2014
1Intravenous Administration
01/2012